BR100 Increased By (0.48%)
BR30 Increased By (0.24%)
KSE100 Increased By (0.43%)
KSE30 Increased By (0.44%)
AGHA 7.75 No Change ▼ 0.00 (0%)
BECO 5.20 Increased By ▲ 0.01 (0.19%)
BML 57.95 Decreased By ▼ -0.71 (-1.21%)
BOP 34.08 Increased By ▲ 0.39 (1.16%)
CNERGY 10.35 Decreased By ▼ -0.26 (-2.45%)
CSIL 5.42 Increased By ▲ 0.12 (2.26%)
FCCL 54.85 Increased By ▲ 1.11 (2.07%)
FFL 16.69 Increased By ▲ 0.23 (1.4%)
FNEL 1.25 Increased By ▲ 0.03 (2.46%)
KEL 7.39 Increased By ▲ 0.11 (1.51%)
KOSM 5.74 Increased By ▲ 0.10 (1.77%)
LOTCHEM 29.55 Decreased By ▼ -0.10 (-0.34%)
MLCF 95.38 Decreased By ▼ -0.98 (-1.02%)
NBP 203.44 Decreased By ▼ -0.09 (-0.04%)
NCPL 57.70 Increased By ▲ 0.85 (1.5%)
NPL 68.99 Increased By ▲ 1.68 (2.5%)
OGDC 317.20 Decreased By ▼ -1.02 (-0.32%)
PACE 10.74 Increased By ▲ 0.11 (1.03%)
PAEL 42.80 Increased By ▲ 1.03 (2.47%)
PIBTL 16.77 Decreased By ▼ -0.04 (-0.24%)
PPL 220.99 Increased By ▲ 0.82 (0.37%)
PRL 50.35 Increased By ▲ 1.30 (2.65%)
PTC 70.55 Increased By ▲ 0.54 (0.77%)
SSGC 28.40 Decreased By ▼ -0.74 (-2.54%)
TBL 9.84 Increased By ▲ 0.07 (0.72%)
TELE 8.80 Decreased By ▼ -0.02 (-0.23%)
TPL 18.25 Increased By ▲ 1.08 (6.29%)
TPLP 12.90 Increased By ▲ 0.39 (3.12%)
TREET 22.80 Increased By ▲ 0.21 (0.93%)
TRG 59.92 Decreased By ▼ -0.30 (-0.5%)

Citi Pharma Limited, one of Pakistan’s leading pharmaceutical companies, refuted on Thursday reports of it planning to establish a new pharmaceutical manufacturing facility in Iraq.

The company, in a notice to the Pakistan Stock Exchange (PSX), said it had come across social media reports that were circulating regarding the establishment of its new facility.

“The company would like to clarify that following our recent participation in the Iraq Expo, discussions were held at an exploratory level with various stakeholders,” the notice to the bourse read.

The company clarified that no formal decisions, agreements, or commitments have been made to enter into or establish operations in the Iraqi market.

The company has formally requested the concerned platforms to remove these posts to prevent the spread of “inaccurate information”, the pharmaceutical said.

“Citi Pharma Limited remains committed to maintaining transparency and ensuring the timely dissemination of accurate information to its shareholders and the general public in accordance with the applicable regulations.”

Comments

Comments are closed for this article.